| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/17/2006 | EP1656020A2 Pyridinylanilides |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1307202B1 Method for the treatment of overactive bladder |
| 05/17/2006 | EP1140881B1 Antithrombotic amides |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1774435A Five-membered heterocyclic derivative |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1256329C Herbicidal substituted benzoylpyrazoles |
| 05/17/2006 | CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/16/2006 | USRE39096 Treatment of skin disorders |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045647 Synergistic mixture of a nitroxyl compound with a quinone alkide having an electron withdrawing group at the 7-position; purification of unsaturated compounds; effective during steady state and after shutoff; storage stability |
| 05/16/2006 | US7045632 Composition and method for a hexadentate ligand and bimetallic complex for polymerization of olefins |
| 05/16/2006 | US7045629 Method for producing-2[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045544 Myocardium; angina pectoris |
| 05/16/2006 | US7045527 Piperidine derivatives |
| 05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
| 05/16/2006 | US7045519 Pyrimidine or pyridine derivatives |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050506A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | WO2006050480A2 Substituted pyridines with activity on syk kinase |
| 05/11/2006 | WO2006050249A1 Diaminotriazole compounds useful as inhibitors of protein kinases |
| 05/11/2006 | WO2006050121A1 Insecticidal n,n-di(heteroarylalkyl) amine derivatives |
| 05/11/2006 | WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006050025A1 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006049486A1 A PREPARATION METHOD FOR SUBSTITUTED 2-(2-PYRIDYLMETHOYLSULPHINYL)-l-H-BENZIMID AZOLES |
| 05/11/2006 | WO2006049304A1 Aryloxy-substituted benzimidazole derivatives |
| 05/11/2006 | WO2006048890A1 Imatinib mesylate crystal form and process for preparation thereof |
| 05/11/2006 | WO2006048771A1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 05/11/2006 | WO2006048761A2 Methods for preparing indazole compounds |
| 05/11/2006 | WO2006048751A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | WO2006048745A1 Methods for preparing indazole compounds |
| 05/11/2006 | WO2006048744A1 Methods of preparing indazole compounds |
| 05/11/2006 | WO2006048251A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/11/2006 | WO2006048249A1 Nicotinamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2006048146A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | WO2006047891A1 Polycyclic aromatics and derivatives thereof and processes for their preparation |
| 05/11/2006 | WO2006047888A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | WO2005101838A8 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 05/11/2006 | WO2005086892A3 Ion channel modulators |
| 05/11/2006 | WO2005030209A8 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 05/11/2006 | WO2005009965A8 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/11/2006 | US20060100436 Antimicrobial quinolones, their compositions, and uses |
| 05/11/2006 | US20060100435 Process for the production of desloratadine |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100259 Process for the preparation of substituted triazole compounds |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100248 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | US20060100244 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100237 Excitatory amino acid receptor antagonists |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | US20060100224 Piperidine ouracil used as a medicament for treating bacterial infections |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100207 Dihydropyridinone derivatives |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060100191 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator |
| 05/11/2006 | DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | CA2591313A1 Methods for preparing indazole compounds |
| 05/11/2006 | CA2588278A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2587489A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | CA2586910A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 05/11/2006 | CA2586271A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2586265A1 Nicotinamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/11/2006 | CA2586177A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | CA2586176A1 Methods for preparing indazole compounds |
| 05/11/2006 | CA2586174A1 Methods of preparing indazole compounds |
| 05/11/2006 | CA2586066A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | CA2585383A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | CA2584808A1 Substituted pyridines with activity on syk kinase |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1655297A1 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 05/10/2006 | EP1655296A1 Thrombin inhibitors |
| 05/10/2006 | EP1655295A1 Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/10/2006 | EP1655284A1 2-Phenylsulfopyrroles |
| 05/10/2006 | EP1654327A1 Cyanin-type compounds having an alkynyl linker arm |